In conclusion, semiquantitative and quantitative analyses of the markers RARA and CRABP2 indicate these proteins as potential biomarkers of tumor progression and their participation in nephroblastoma tumorigenesis. This evidence concerns the gene CRABP2 and Wilms tumor.